RNS vs VNS

Skip to main content
NeuroPace, Inc
  • Patients
  • Providers
  • Corporate
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search
Could the RNS System be right for me? Start Quiz

RNS® System and VNS Therapy – What are the Differences?

The RNS System is the only FDA-approved epilepsy device that recognizes and responds to what’s happening in your brain in real-time to prevent seizures at their source.

RNS System vs. VNS Therapy

The RNS System VNS Therapy
Where stimulation is delivered RNS delivers stimulation to the seizure source Seizure source1
(in the brain) 		VNS delivers stimulation to the vagus nerve Vagus nerve2
(in the neck)
Monitors & responds to brain activity Yes No
Records EEG data for your doctor to review Yes No
Stimulation side-effects No chronic stimulation side-effects3 Potential voice changes and hoarseness4
The RNS System
Where stimulation is delivered RNS delivers stimulation to the seizure source Seizure source1
(in the brain)
Monitors & responds to brain activity Yes
Records EEG data for your doctor to review Yes
Stimulation side-effects No chronic stimulation side-effects3
VNS Therapy
Where stimulation is delivered VNS delivers stimulation to the vagus nerve Vagus nerve2
(in the neck)
Monitors & responds to brain activity No
Records EEG data for your doctor to review No
Stimulation side-effects Potential voice changes and hoarseness4

How the RNS System Works

1. Razavi, et al. Epilepsia. 2020. 2. LivaNova VNS Therapy System Epilepsy Physician Manual, May 2020 3. Nair, et al. Neurology. 2020. 4. Spregners M, et al., Cochrane Review, 2017

Hear from people who have had the RNS System and VNS Therapy


 

 

Hear from patients and caregivers who have had experiences with both
therapies.

Every individual’s seizures are different and individual results will vary.

 

 

Paul, Susan’s son, used to have seizures that would throw him out of bed.
“After the RNS, his seizures look more like a sneeze.” -Susan

Every individual’s seizures are different and individual results will vary.

 

 

Paul has been treated with both the RNS System and VNS Therapy.

The RNS System can recognize the onset of Paul’s seizures and automatically send stimulation to stop the seizures.

Every individual’s seizures are different and individual results will vary.

 

 

The RNS System recognizes & responds to your specific brain patterns.

Every individual’s seizures are different and individual results will vary.

 

 

With the RNS System, Josh can feel a seizure stop before it progresses

Every individual’s seizures are different and individual results will vary.

 

 

Kimball has had the RNS System and VNS Therapy for 10 years each. One thing he likes about the RNS System is that it works without him feeling anything.

Every individual’s seizures are different and individual results will vary.

 

 

“In our experience, the NeuroPace RNS System has been much more impactful” – Julie (wife of Josh, who has the RNS System and VNS Therapy)

Every individual’s seizures are different and individual results will vary.

Courtney tried VNS therapy, but she achieved seizure control with the RNS System.

In 2008, she tried VNS Therapy, but it didn’t help with her seizures. It also affected her vocal cords when she tried to speak or sing. Now with the RNS System she is close to being seizure-free.

“To my amazement, the RNS System soon reduced the frequency and severity of my seizures… As my doctor has fine-tuned my medications, I’ve reached the point where I am close to being seizure-free.” -Courtney*

Courtney

*Every person’s seizures are different and individual results will vary

FAQ

Could I be a candidate for the RNS System if I already had the VNS Therapy?

Yes, having had VNS Therapy does not exclude you from being a candidate for the RNS System. The RNS System is for individuals aged 18 and older who have tried at least 2 anti-seizure medications but still suffer from focal seizures that come from one or two areas of the brain. There are many individuals who have also had VNS Therapy. You can read about some of their stories by selecting the “Prior VNS” filter on the stories page. 

How is the RNS System different than VNS Therapy?

The RNS System is the only FDA-approved epilepsy device that recognizes and responds to what’s happening in a person’s brain in real time to prevent seizures at their source. You can read about more of the differences in the chart at the top of the page.

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

CORPORATE

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure

  • PATIENTS

    Safety

  • PROVIDERS

    Legal

  • INVESTORS

    Privacy Policy

  • CORPORATE

1-866-726-3876 24-hr Support Line

© 2025 NeuroPace, Inc.

This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using the site, you consent to the placement of these cookies. You may at any time change the settings regarding cookies. Read our privacy statement to learn more. Do not sell my personal information.

X
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
JSESSIONIDsessionThe JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
s_ccsessionThis cookie is set by Adobe Analytics to determine if cookies are enabled or not.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
ac_enable_tracking1 monthThis cookie is set by Active Campaign to denote that traffic is enabled for the website.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_UA-55828317-31 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
demdex5 months 27 daysThe demdex cookie, set under the domain demdex.net, is used by Adobe Audience Manager to help identify a unique visitor across domains.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising, after visiting the website.
fr3 monthsFacebook sets this cookie to show relevant advertisements to users by tracking user behaviour across the web, on sites that have Facebook pixel or Facebook social plugin.
VISITOR_INFO1_LIVE5 months 27 daysA cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSCsessionYSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devicesneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-idneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
AMCV_98CF678254E93B1B0A4C98A5AdobeOrg2 yearsNo description
AMCVS_98CF678254E93B1B0A4C98A5AdobeOrgsessionNo description
DrupalVisitorMobilesessionNo description available.
FASRVsessionNo description available.
FORMASSEMBLYsessionNo description available.
prism_7986813311 monthNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Are you taking this survey for yourself or a loved one?


















If you are an existing RNS System patient, please direct questions to your physician or NeuroPace Customer Service at (866) 726.3876. Quiz submissions from existing RNS System patients are not accepted.

How old are you or your loved one? 
Do you or your loved one still have seizures even after trying 2 or more different anti-seizure medications?

Which of the following types of epilepsy have you or your loved one been diagnosed with?
Which of the following procedures have you or your loved one had (check all that apply)?
Are you being treated at one of the epilepsy centers below? If yes, please select that center. If your center is not on the list, please select “My center is not on the list.”
Filter
Search


It appears you may be a candidate!

To learn more about the RNS System and centers offering the RNS System, please include your phone number below and a Nurse Educator will contact you. 

If you do not provide your phone number, we will only email information about the RNS System to you.





By submitting this form, I give permission for NeuroPace to contact me via phone, email, or text message from time to time including regular informational emails. I understand that I can opt out of one or all communication methods at any time. NeuroPace will never sell my data or personal information, and I agree to the company's privacy policy.
The RNS System is not currently FDA approved for patients under the age of 18. However, we are currently enrolling patients in the RESPONSE Clinical Study to evaluate the RNS System in teens ages 12 through 17. To learn more, click "Done".

It appears that you may not be an appropriate candidate for the RNS® System at this time. It is FDA approved for people 18+ years of age with focal epilepsy who are still having seizures despite trying two or more medications. 
It appears your loved one may not be an appropriate candidate for the RNS® System at this time. It is FDA approved for people 18+ years of age with focal epilepsy who are still having seizures despite trying two or more medications. 

The RNS System is not currently FDA approved for patients with generalized epilepsy. However, we will be enrolling patients in the NAUTILUS Clinical Study to evaluate the RNS System in patients with primary generalized epilepsy. To learn more visit  https://www.neuropace.com/providers/clinical-research/



reCAPTCHA helps prevent automated form spam.
The submit button will be disabled until you complete the CAPTCHA.


Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.

  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials